Literature DB >> 17986445

Long range communication in the envelope protein domain III and its effect on the resistance of West Nile virus to antibody-mediated neutralization.

Rodrigo A Maillard1, Matthew Jordan, David W C Beasley, Alan D T Barrett, J Ching Lee.   

Abstract

The envelope protein domain III (ED3) of West Nile virus is the major virus-specific neutralization domain and harbors most of the critical mutations that induce resistance against antibody-mediated neutralization. We investigated the molecular mechanisms of neutralization resistance by studying the biophysical perturbations of monoclonal antibody (mAb)-resistant mutations on ED3 wild type. Our results showed that although the solution structure between ED3 wild type and mutants was preserved, the mutations that confer the highest degree of resistance to mAbs showed low protein stability and high local dynamic motions. Interestingly, the latter was observed in regions outside the mutation sites, indicating long range communications within ED3. Thus, we hypothesized that the mechanisms involved in resistance to mAb neutralization may include, in addition to mutations in the epitope, long range effects among distant structural elements. This hypothesis is consistent with reported mutations in other flaviviruses whose surfaces are not exposed for the interaction with other macromolecules, yet they confer mAb neutralization resistance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17986445     DOI: 10.1074/jbc.M706031200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Recovery of West Nile Virus Envelope Protein Domain III Chimeras with Altered Antigenicity and Mouse Virulence.

Authors:  Alexander J McAuley; Maricela Torres; Jessica A Plante; Claire Y-H Huang; Dennis A Bente; David W C Beasley
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

2.  PCP consensus sequences of flaviviruses: correlating variance with vector competence and disease phenotype.

Authors:  Petr Danecek; Wenzhe Lu; Catherine H Schein
Journal:  J Mol Biol       Date:  2009-12-04       Impact factor: 5.469

3.  Fluorescence lifetimes of tryptophan: structural origin and relation with So --> 1Lb and So --> 1La transitions.

Authors:  Jihad René Albani
Journal:  J Fluoresc       Date:  2009-06-16       Impact factor: 2.217

4.  Dengue virus neutralization by human immune sera: role of envelope protein domain III-reactive antibody.

Authors:  W M P B Wahala; Annette A Kraus; Laura B Haymore; Mary Ann Accavitti-Loper; Aravinda M de Silva
Journal:  Virology       Date:  2009-07-24       Impact factor: 3.616

5.  Flavivirus-induced antibody cross-reactivity.

Authors:  Karen L Mansfield; Daniel L Horton; Nicholas Johnson; Li Li; Alan D T Barrett; Derek J Smith; Sareen E Galbraith; Tom Solomon; Anthony R Fooks
Journal:  J Gen Virol       Date:  2011-09-07       Impact factor: 3.891

6.  Thermodynamic mechanism for the evasion of antibody neutralization in flaviviruses.

Authors:  Rodrigo A Maillard; Tong Liu; David W C Beasley; Alan D T Barrett; Vincent J Hilser; J Ching Lee
Journal:  J Am Chem Soc       Date:  2014-07-08       Impact factor: 15.419

7.  Molecular Changes in Dengue Envelope Protein Domain III upon Interaction with Glycosaminoglycans.

Authors:  James G Hyatt; Sylvain Prévost; Juliette M Devos; Courtney J Mycroft-West; Mark A Skidmore; Anja Winter
Journal:  Pathogens       Date:  2020-11-11

8.  In silico construction of a multiepitope Zika virus vaccine using immunoinformatics tools.

Authors:  Ana Clara Barbosa Antonelli; Vinnycius Pereira Almeida; Fernanda Oliveira Feitosa de Castro; Jacyelle Medeiros Silva; Irmtraut Araci Hoffmann Pfrimer; Edecio Cunha-Neto; Andréa Queiroz Maranhão; Marcelo Macedo Brígido; Renato Oliveira Resende; Anamélia Lorenzetti Bocca; Simone Gonçalves Fonseca
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

9.  Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens.

Authors:  Wayne D Crill; Holly R Hughes; Mark J Delorey; Gwong-Jen J Chang
Journal:  PLoS One       Date:  2009-04-01       Impact factor: 3.240

10.  Impact of yellow fever virus envelope protein on wild-type and vaccine epitopes and tissue tropism.

Authors:  Emily H Davis; Binbin Wang; Mellodee White; Yan-Jang S Huang; Vanessa V Sarathy; Tian Wang; Nigel Bourne; Stephen Higgs; Alan D T Barrett
Journal:  NPJ Vaccines       Date:  2022-03-23       Impact factor: 9.399

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.